DNMT3A and acute myeloid leukemia: Two samples obtained from AML patients at diagnosis containing approximately 50 % of DNMT3A R882H mutations exceeded the threshold at a similar cycle as the 10° dilution of the plasmid (29.14/29.11 vs. 28.65; Fig. 5.b).